Fixed Price IPO | ₹35 Cr | Listed at BSE SME | Mon, Sep 26, 2022 - Thu, Sep 29, 2022
Trident Lifeline IPO is a fixed price issue of ₹35.34 crores. The issue is entirely a fresh issue of 0.35 crore shares of ₹35.34 crore.
Trident Lifeline IPO bidding started from Sep 26, 2022 and ended on Sep 29, 2022. The allotment for Trident Lifeline IPO was finalized on Oct 4, 2022. The shares got listed on BSE SME on Oct 10, 2022.
Trident Lifeline IPO price is ₹101 per share. The lot size for an application is 1,200. The minimum amount of investment required by an individual investor (retail) is ₹1,21,200 (1200 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (2,400 shares), amounting to ₹2,42,400.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Sunflower Broking Pvt.Ltd..
Refer to Trident Lifeline IPO RHP for detailed Information.
IPO Open
Mon, Sep 26, 2022
IPO Close
Thu, Sep 29, 2022
Issue Price
₹101 per share
Market Cap (Pre-IPO)
₹116.14 Cr
| IPO Date | 26 to 29 Sep, 2022 |
| Listed on | Mon, Oct 10, 2022 |
| Face Value | ₹10 per share |
| Issue Price | ₹101 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 34,99,200 shares (agg. up to ₹35 Cr) |
| Reserved for Market Maker | 1,75,200 shares Sunflower Broking Pvt.Ltd. (agg. up to ₹2 Cr) |
| Fresh Issue (Ex Market Maker) | 33,24,000 shares (agg. up to ₹34 Cr) |
| Net Offered to Public | 33,24,000 shares (agg. up to ₹34 Cr) |
| Share Holding Pre Issue | 80,00,000 shares |
| Share Holding Post Issue | 1,14,99,200 shares |
| BSE Script Code | 543616 |
| ISIN | INE0MKA01014 |
Trident Lifeline IPO comprises a total issue size of 34,99,200 shares. The net offer to the public is 33,24,000 shares, after excluding 1,75,200 shares allotted on a firm basis. Of the Net offer 16,62,000 (50.00%) allocated to NII 16,62,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 16,62,000 | 50.00% | 47.50% |
| Retail Shares Offered | 16,62,000 | 50.00% | 47.50% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,75,200 | 5.01% | |
| Total Shares Offered | 34,99,200 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,200 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,21,200 |
| Retail (Max) | 1 | 1,200 | ₹1,21,200 |
| HNI (Min) | 2 | 2,400 | ₹2,42,400 |
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.
Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.
Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).
Trident Lifeline core business categories:
1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.
2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.
The company operate in India as well as African, Latin American and East Indian Countries. The company have a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venuzela.
| Period Ended | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|
| Assets | 13.86 | 11.44 | 6.39 |
| Total Income | 22.37 | 9.78 | 5.01 |
| Profit After Tax | 2.27 | 0.63 | -0.80 |
| NET Worth | 4.80 | -0.47 | -3.00 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirements | 20.50 |
| 2 | Product registration in the International Markets | 5.14 |
| 3 | General Corporate Purpose | 6.71 |
| 4 | Public Issue Expenses | 3.00 |
| KPI | |
|---|---|
| RoNW | 47.33 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 3.98 | |
| P/E (x) | 51.53 | |
| Promoter Holding | 100% | 69.57% |
| Market Cap | ₹116.14 Cr. |
The Trident Lifeline IPO is subscribed 1.34 times on September 29, 2022 6:59:00 PM (Day 4). The public issue subscribed 0.98 times in the retail category, [.] times in the QIB category, and 1.69 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 1.69 | 16,62,000 | 28,15,200 |
| Retail | 0.98 | 16,62,000 | 16,36,800 |
| Total | 1.34 | 33,24,000 | 44,52,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees including Underwriting Commission, brokerage and Selling & Marketing commission | 2.72 |
| 2 | Fees Payable to Registrar to the Issue | 0.01 |
| 3 | Fees Payable Advertising, Marketing Expenses and Printing Expenses | 0.14 |
| 4 | Fees Payable to Regulators including Stock Exchanges and other Intermediaries | 0.06 |
| 5 | Fees payable to Peer Review Auditor | 0.01 |
| 6 | Fees Payable to Market Maker (for Two Years) | 0.06 |
| 7 | Escrow Bank Fees | 0.01 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹101.00 |
| Open | ₹105.00 |
| Low | ₹105.00 |
| High | ₹110.25 |
| Last Trade | ₹108.15 |
Lead Manager Reports
Trident Lifeline IPO is a SME IPO of 34,99,200 equity shares of the face value of ₹10 aggregating up to ₹35 Crores. The issue is priced at ₹101 per share. The minimum order quantity is 1200.
The IPO opens on Mon, Sep 26, 2022, and closes on Thu, Sep 29, 2022.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Trident Lifeline IPO using UPI as a payment gateway. Zerodha customers can apply in Trident Lifeline IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Trident Lifeline IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Trident Lifeline IPO opens on Mon, Sep 26, 2022 and closes on Thu, Sep 29, 2022.
Trident Lifeline IPO lot size is 1200, and the minimum amount required for application is ₹1,21,200.
You can apply in Trident Lifeline IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Trident Lifeline IPO will be done on Tuesday, October 4, 2022, and the allotted shares will be credited to your demat account by Fri, Oct 7, 2022. Check the Trident Lifeline IPO allotment status.
The Trident Lifeline IPO listing date is on Mon, Oct 10, 2022.
